| 1 | served | 2,229 |
| 2 | regarded | 1,879 |
| 3 | viewed | 1,330 |
| 4 | acted | 424 |
| 5 | misdiagnosed | 186 |
| 6 | conceptualized | 114 |
| 7 | misinterpreted | 73 |
| 8 | construed | 34 |
| 9 | heralded | 25 |
| 10 | conceptualised | 21 |
| 11 | misidentified | 19 |
| 12 | hailed | 16 |
| 13 | rewritten | 6 |
| 14 | fee-based | 5 |
| 15 | prequalified | 5 |
| 16 | co-developed | 4 |
| 17 | reinvented | 4 |
| 18 | masquerading | 3 |
| 19 | abluminally | 2 |
| 20 | actualizes | 2 |
| 21 | animal-bone | 2 |
| 22 | demonized | 2 |
| 23 | denounced | 2 |
| 24 | favorites | 2 |
| 25 | mischaracterized | 2 |
| 26 | pyridine-5,7-dione | 2 |
| 27 | recategorized | 2 |
| 28 | receptor-and | 2 |
| 29 | redressed | 2 |
| 30 | relabeled | 2 |
| 31 | +31/-32 | 1 |
| 32 | +ftc/tdf | 1 |
| 33 | -* | 1 |
| 34 | -1,3,5-triazinane | 1 |
| 35 | -2,3,4,9-tetrahydro-1h-carbazole-6-carboxamides | 1 |
| 36 | -2-morpholino-4-oxo-4h-chromene-6-carboxamides | 1 |
| 37 | -2h-pyrrole-5-one | 1 |
| 38 | -3,5-diphenyl-1h-1,2,4-triazole | 1 |
| 39 | -3/4b | 1 |
| 40 | -5-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-one | 1 |
| 41 | -7-nitro-2-1,3-benzoxadiazol-4-yl-sphingomyelin | 1 |
| 42 | -carvone | 1 |
| 43 | -citalopram | 1 |
| 44 | -crotonaldehyde | 1 |
| 45 | -d-galactoside | 1 |
| 46 | -deoxynivalenol | 1 |
| 47 | -monophos | 1 |
| 48 | -mris | 1 |
| 49 | -ngal | 1 |
| 50 | -sn-glycero-3-phosphocholine | 1 |
| 51 | -ygcgac | 1 |
| 52 | .thiazides | 1 |
| 53 | /k+-atpase | 1 |
| 54 | /oy-tes-1 | 1 |
| 55 | /rtv+ftc/tdf | 1 |
| 56 | /testosterone | 1 |
| 57 | 2/bis-sulfoxide | 1 |
| 58 | 2/cui | 1 |
| 59 | 3-phenyl-3-methyl-pyrrolidine-2,5-diones | 1 |
| 60 | 4,160 | 1 |
| 61 | 60601-1-6 | 1 |
| 62 | 8a-k | 1 |
| 63 | accepted.the | 1 |
| 64 | adminsitered | 1 |
| 65 | antipodal | 1 |
| 66 | atcc25922 | 1 |
| 67 | available-such | 1 |
| 68 | avails | 1 |
| 69 | axellus | 1 |
| 70 | azetidine-3,3-dicarboxylate | 1 |
| 71 | b-folfiri | 1 |
| 72 | bis-mercaptoacetate | 1 |
| 73 | bunh2 | 1 |
| 74 | ci=0.58-0.65 | 1 |
| 75 | ci=76-89.6 | 1 |
| 76 | coelomitis | 1 |
| 77 | comfirmed | 1 |
| 78 | conducted.the | 1 |
| 79 | cyclobutane-1,1-dicarboxylate | 1 |
| 80 | cyto-/chemokines | 1 |
| 81 | derided | 1 |
| 82 | dithiophene-2,6-dicarboxylate | 1 |
| 83 | dnac | 1 |
| 84 | dolton | 1 |
| 85 | everytime | 1 |
| 86 | f-fluroroethylation | 1 |
| 87 | fc40 | 1 |
| 88 | framed-either | 1 |
| 89 | hex-4-enoates | 1 |
| 90 | hypermetamorphic | 1 |
| 91 | iii-vii | 1 |
| 92 | included- | 1 |
| 93 | indirect/societal | 1 |
| 94 | instinctual | 1 |
| 95 | involved.we | 1 |
| 96 | k12-17 | 1 |
| 97 | licorne | 1 |
| 98 | methylphosphonates | 1 |
| 99 | none-smokers | 1 |
| 100 | p123 | 1 |
| 101 | panicle1 | 1 |
| 102 | paravaginale | 1 |
| 103 | pd/c-cui-pph3 | 1 |
| 104 | pentanediamines | 1 |
| 105 | polarizes | 1 |
| 106 | promoted/recommended | 1 |
| 107 | pseudo-mirror | 1 |
| 108 | pseudomediation | 1 |
| 109 | pyridin-2-one | 1 |
| 110 | r972 | 1 |
| 111 | re-appraised | 1 |
| 112 | re-conceptualized | 1 |
| 113 | reagarded | 1 |
| 114 | redissolves | 1 |
| 115 | rl100 | 1 |
| 116 | self-describing | 1 |
| 117 | self-stabilizing | 1 |
| 118 | side-stepped | 1 |
| 119 | spd465 | 1 |
| 120 | subject-specifically | 1 |
| 121 | teqing | 1 |
| 122 | thiophene-2,3-dicarbonitrile | 1 |
| 123 | underacknowledged | 1 |
| 124 | ±bortezomib | 1 |
| 1 | +31/-32 | 1 |
| 2 | +ftc/tdf | 1 |
| 3 | -* | 1 |
| 4 | -1,3,5-triazinane | 1 |
| 5 | -2,3,4,9-tetrahydro-1h-carbazole-6-carboxamides | 1 |
| 6 | -2-morpholino-4-oxo-4h-chromene-6-carboxamides | 1 |
| 7 | -2h-pyrrole-5-one | 1 |
| 8 | -3,5-diphenyl-1h-1,2,4-triazole | 1 |
| 9 | -3/4b | 1 |
| 10 | -5-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-one | 1 |
| 11 | -7-nitro-2-1,3-benzoxadiazol-4-yl-sphingomyelin | 1 |
| 12 | -carvone | 1 |
| 13 | -citalopram | 1 |
| 14 | -crotonaldehyde | 1 |
| 15 | -d-galactoside | 1 |
| 16 | -deoxynivalenol | 1 |
| 17 | -monophos | 1 |
| 18 | -mris | 1 |
| 19 | -ngal | 1 |
| 20 | -sn-glycero-3-phosphocholine | 1 |
| 21 | -ygcgac | 1 |
| 22 | .thiazides | 1 |
| 23 | /k+-atpase | 1 |
| 24 | /oy-tes-1 | 1 |
| 25 | /rtv+ftc/tdf | 1 |
| 26 | /testosterone | 1 |
| 27 | 2/bis-sulfoxide | 1 |
| 28 | 2/cui | 1 |
| 29 | 3-phenyl-3-methyl-pyrrolidine-2,5-diones | 1 |
| 30 | 4,160 | 1 |
| 31 | 60601-1-6 | 1 |
| 32 | 8a-k | 1 |
| 33 | abluminally | 2 |
| 34 | accepted.the | 1 |
| 35 | acted | 424 |
| 36 | actualizes | 2 |
| 37 | adminsitered | 1 |
| 38 | animal-bone | 2 |
| 39 | antipodal | 1 |
| 40 | atcc25922 | 1 |
| 41 | available-such | 1 |
| 42 | avails | 1 |
| 43 | axellus | 1 |
| 44 | azetidine-3,3-dicarboxylate | 1 |
| 45 | b-folfiri | 1 |
| 46 | bis-mercaptoacetate | 1 |
| 47 | bunh2 | 1 |
| 48 | ci=0.58-0.65 | 1 |
| 49 | ci=76-89.6 | 1 |
| 50 | co-developed | 4 |
| 51 | coelomitis | 1 |
| 52 | comfirmed | 1 |
| 53 | conceptualised | 21 |
| 54 | conceptualized | 114 |
| 55 | conducted.the | 1 |
| 56 | construed | 34 |
| 57 | cyclobutane-1,1-dicarboxylate | 1 |
| 58 | cyto-/chemokines | 1 |
| 59 | demonized | 2 |
| 60 | denounced | 2 |
| 61 | derided | 1 |
| 62 | dithiophene-2,6-dicarboxylate | 1 |
| 63 | dnac | 1 |
| 64 | dolton | 1 |
| 65 | everytime | 1 |
| 66 | f-fluroroethylation | 1 |
| 67 | favorites | 2 |
| 68 | fc40 | 1 |
| 69 | fee-based | 5 |
| 70 | framed-either | 1 |
| 71 | hailed | 16 |
| 72 | heralded | 25 |
| 73 | hex-4-enoates | 1 |
| 74 | hypermetamorphic | 1 |
| 75 | iii-vii | 1 |
| 76 | included- | 1 |
| 77 | indirect/societal | 1 |
| 78 | instinctual | 1 |
| 79 | involved.we | 1 |
| 80 | k12-17 | 1 |
| 81 | licorne | 1 |
| 82 | masquerading | 3 |
| 83 | methylphosphonates | 1 |
| 84 | mischaracterized | 2 |
| 85 | misdiagnosed | 186 |
| 86 | misidentified | 19 |
| 87 | misinterpreted | 73 |
| 88 | none-smokers | 1 |
| 89 | p123 | 1 |
| 90 | panicle1 | 1 |
| 91 | paravaginale | 1 |
| 92 | pd/c-cui-pph3 | 1 |
| 93 | pentanediamines | 1 |
| 94 | polarizes | 1 |
| 95 | prequalified | 5 |
| 96 | promoted/recommended | 1 |
| 97 | pseudo-mirror | 1 |
| 98 | pseudomediation | 1 |
| 99 | pyridin-2-one | 1 |
| 100 | pyridine-5,7-dione | 2 |
| 101 | r972 | 1 |
| 102 | re-appraised | 1 |
| 103 | re-conceptualized | 1 |
| 104 | reagarded | 1 |
| 105 | recategorized | 2 |
| 106 | receptor-and | 2 |
| 107 | redissolves | 1 |
| 108 | redressed | 2 |
| 109 | regarded | 1,879 |
| 110 | reinvented | 4 |
| 111 | relabeled | 2 |
| 112 | rewritten | 6 |
| 113 | rl100 | 1 |
| 114 | self-describing | 1 |
| 115 | self-stabilizing | 1 |
| 116 | served | 2,229 |
| 117 | side-stepped | 1 |
| 118 | spd465 | 1 |
| 119 | subject-specifically | 1 |
| 120 | teqing | 1 |
| 121 | thiophene-2,3-dicarbonitrile | 1 |
| 122 | underacknowledged | 1 |
| 123 | viewed | 1,330 |
| 124 | ±bortezomib | 1 |
| 1 | -* | 1 |
| 2 | included- | 1 |
| 3 | rl100 | 1 |
| 4 | fc40 | 1 |
| 5 | 4,160 | 1 |
| 6 | /oy-tes-1 | 1 |
| 7 | panicle1 | 1 |
| 8 | atcc25922 | 1 |
| 9 | +31/-32 | 1 |
| 10 | r972 | 1 |
| 11 | bunh2 | 1 |
| 12 | p123 | 1 |
| 13 | pd/c-cui-pph3 | 1 |
| 14 | ci=0.58-0.65 | 1 |
| 15 | spd465 | 1 |
| 16 | 60601-1-6 | 1 |
| 17 | ci=76-89.6 | 1 |
| 18 | k12-17 | 1 |
| 19 | -3/4b | 1 |
| 20 | ±bortezomib | 1 |
| 21 | -ygcgac | 1 |
| 22 | dnac | 1 |
| 23 | hypermetamorphic | 1 |
| 24 | denounced | 2 |
| 25 | derided | 1 |
| 26 | heralded | 25 |
| 27 | promoted/recommended | 1 |
| 28 | reagarded | 1 |
| 29 | regarded | 1,879 |
| 30 | underacknowledged | 1 |
| 31 | prequalified | 5 |
| 32 | misidentified | 19 |
| 33 | relabeled | 2 |
| 34 | hailed | 16 |
| 35 | comfirmed | 1 |
| 36 | co-developed | 4 |
| 37 | side-stepped | 1 |
| 38 | adminsitered | 1 |
| 39 | fee-based | 5 |
| 40 | re-appraised | 1 |
| 41 | conceptualised | 21 |
| 42 | misdiagnosed | 186 |
| 43 | redressed | 2 |
| 44 | acted | 424 |
| 45 | misinterpreted | 73 |
| 46 | reinvented | 4 |
| 47 | construed | 34 |
| 48 | served | 2,229 |
| 49 | viewed | 1,330 |
| 50 | conceptualized | 114 |
| 51 | re-conceptualized | 1 |
| 52 | demonized | 2 |
| 53 | mischaracterized | 2 |
| 54 | recategorized | 2 |
| 55 | receptor-and | 2 |
| 56 | -d-galactoside | 1 |
| 57 | 2/bis-sulfoxide | 1 |
| 58 | -crotonaldehyde | 1 |
| 59 | conducted.the | 1 |
| 60 | accepted.the | 1 |
| 61 | paravaginale | 1 |
| 62 | thiophene-2,3-dicarbonitrile | 1 |
| 63 | -3,5-diphenyl-1h-1,2,4-triazole | 1 |
| 64 | everytime | 1 |
| 65 | -1,3,5-triazinane | 1 |
| 66 | -sn-glycero-3-phosphocholine | 1 |
| 67 | -5-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-one | 1 |
| 68 | pyridin-2-one | 1 |
| 69 | -2h-pyrrole-5-one | 1 |
| 70 | animal-bone | 2 |
| 71 | pyridine-5,7-dione | 2 |
| 72 | /testosterone | 1 |
| 73 | -carvone | 1 |
| 74 | licorne | 1 |
| 75 | /k+-atpase | 1 |
| 76 | cyclobutane-1,1-dicarboxylate | 1 |
| 77 | azetidine-3,3-dicarboxylate | 1 |
| 78 | dithiophene-2,6-dicarboxylate | 1 |
| 79 | bis-mercaptoacetate | 1 |
| 80 | involved.we | 1 |
| 81 | +ftc/tdf | 1 |
| 82 | /rtv+ftc/tdf | 1 |
| 83 | self-describing | 1 |
| 84 | masquerading | 3 |
| 85 | teqing | 1 |
| 86 | self-stabilizing | 1 |
| 87 | available-such | 1 |
| 88 | iii-vii | 1 |
| 89 | b-folfiri | 1 |
| 90 | 2/cui | 1 |
| 91 | 8a-k | 1 |
| 92 | antipodal | 1 |
| 93 | -ngal | 1 |
| 94 | indirect/societal | 1 |
| 95 | instinctual | 1 |
| 96 | -deoxynivalenol | 1 |
| 97 | -citalopram | 1 |
| 98 | rewritten | 6 |
| 99 | -7-nitro-2-1,3-benzoxadiazol-4-yl-sphingomyelin | 1 |
| 100 | pseudomediation | 1 |
| 101 | f-fluroroethylation | 1 |
| 102 | dolton | 1 |
| 103 | framed-either | 1 |
| 104 | pseudo-mirror | 1 |
| 105 | -2,3,4,9-tetrahydro-1h-carbazole-6-carboxamides | 1 |
| 106 | -2-morpholino-4-oxo-4h-chromene-6-carboxamides | 1 |
| 107 | .thiazides | 1 |
| 108 | cyto-/chemokines | 1 |
| 109 | pentanediamines | 1 |
| 110 | 3-phenyl-3-methyl-pyrrolidine-2,5-diones | 1 |
| 111 | methylphosphonates | 1 |
| 112 | hex-4-enoates | 1 |
| 113 | favorites | 2 |
| 114 | redissolves | 1 |
| 115 | actualizes | 2 |
| 116 | polarizes | 1 |
| 117 | -mris | 1 |
| 118 | coelomitis | 1 |
| 119 | avails | 1 |
| 120 | -monophos | 1 |
| 121 | none-smokers | 1 |
| 122 | axellus | 1 |
| 123 | subject-specifically | 1 |
| 124 | abluminally | 2 |